MDCX — Medicus Pharma Balance Sheet
0.000.00%
- $52.99m
- $47.68m
Annual balance sheet for Medicus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | fx Final | fx Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.082 | 0.001 | 0.268 | 1.72 | 4.16 |
Prepaid Expenses | |||||
Total Current Assets | 0.082 | 0.001 | 0.283 | 1.89 | 5.38 |
Net Property, Plant And Equipment | — | — | — | — | 0.269 |
Other Long Term Assets | |||||
Total Assets | 0.082 | 0.001 | 0.283 | 1.89 | 5.65 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.402 | 0.227 | 12.5 | 0.782 | 2.31 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.402 | 0.227 | 12.5 | 0.782 | 2.51 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.321 | -0.226 | -12.2 | 1.11 | 3.13 |
Total Liabilities & Shareholders' Equity | 0.082 | 0.001 | 0.283 | 1.89 | 5.65 |
Total Common Shares Outstanding |